Previous close | 23.90 |
Open | 0.00 |
Bid | 0.00 x N/A |
Ask | 0.00 x N/A |
Day's range | 0.00 - 0.00 |
52-week range | |
Volume | |
Avg. volume | 886 |
Market cap | N/A |
Beta (5Y monthly) | 0.90 |
PE ratio (TTM) | 0.43 |
EPS (TTM) | 0.56 |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Oslo, Norway, 16 April 2024 Vistin Pharma ASA will release its first quarter results on Wednesday 24th of April 2024. Vistin Pharma will host a conference call for all shareholders and interested parties at the same day; Wednesday 24th of April at 08:30 CET. There will be a Q&A session following the management discussion. The conference call will be held in English. The first quarter conference call will be available via web and audio through the following access points: Webcast: https://edge.me
Oslo, Norway, 4 March 2024 Vistin Pharma has aquired a 15% share in CF Pharma Kft. CF Pharma is an API CDMO located in Budapest, Hungary with a broad customer base of recognized international pharmaceutical companies. CF Pharma has a proven track record in developing and commercializing Active Pharmaceutical Ingredients (APIs). The group/company currently has five commercial APIs on the market, with another eight APIs under development. The transaction price consists of a base price and an earn-
The Board of Directors of Vistin Pharma ASA plans to propose to distribute a cash dividend of total NOK 1.00 per share, to be paid partly in June and November, for the accounting year of 2023. The formal decision regarding the dividend will be made on the company's Annual General Meeting, which will be held on 23 May 2024. Dividend amount (per share): NOK 0.50 Declared currency: NOK Last day including right: 4 June 2024 Ex-date: 5 June 2024 Record date: 6 June 2024 Payment date (on or about): 18